Literature DB >> 7774715

Structural determination of two N-linked glycans isolated from recombinant human lactoferrin expressed in BHK cells.

D Legrand1, V Salmon, B Coddeville, M Benaissa, Y Plancke, G Spik.   

Abstract

A full-length cDNA coding for human lactoferrin was isolated from a mammary gland library and the recombinant protein was expressed in BHK cells as described by Stowell K. M. et al. [1991, Biochem. J. 276, 349-355]. Two N-linked glycans from purified recombinant lactoferrin were released by hydrazinolysis and analyzed by 400-MHz 1H-NMR spectroscopy. The identified structures corresponded to N-acetyllactosaminic biantennary glycans and were alpha-2,3-disialylated forms (80%) or alpha-2,3-monosialylated (20%) forms. Moreover, 70% of total glycans were alpha-1,6-fucosylated at the GlcNAc residue linked to asparagine. In regard to its glycan moiety, the recombinant glycoprotein is close to native lactoferrins from milk or leucocytes but shows specific structural features which should be taken into account prior to in vivo and in vitro biological studies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774715     DOI: 10.1016/0014-5793(95)00441-b

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Structure and biological actions of lactoferrin.

Authors:  J H Nuijens; P H van Berkel; F L Schanbacher
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

2.  The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.

Authors:  D Legrand; P H van Berkel; V Salmon; H A van Veen; M C Slomianny; J H Nuijens; G Spik
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

3.  Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants.

Authors:  P H van Berkel; H A van Veen; M E Geerts; H A de Boer; J H Nuijens
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

4.  Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein.

Authors:  E Elass-Rochard; D Legrand; V Salmon; A Roseanu; M Trif; P S Tobias; J Mazurier; G Spik
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response.

Authors:  Byung-Kwon Choi; Jeffrey K Actor; Sandra Rios; Marc d'Anjou; Terrance A Stadheim; Shannon Warburton; Erin Giaccone; Michael Cukan; Huijuan Li; Angela Kull; Nathan Sharkey; Paul Gollnick; Maja Kocieba; Jolanta Artym; Michal Zimecki; Marian L Kruzel; Stefan Wildt
Journal:  Glycoconj J       Date:  2008-03-26       Impact factor: 2.916

6.  Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.

Authors:  E Elass-Rochard; A Roseanu; D Legrand; M Trif; V Salmon; C Motas; J Montreuil; G Spik
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

7.  N-glycosylation potential of maize: the human lactoferrin used as a model.

Authors:  B Samyn-Petit; V Gruber; C Flahaut; J P Wajda-Dubos; S Farrer; A Pons; G Desmaizieres; M C Slomianny; M Theisen; P Delannoy
Journal:  Glycoconj J       Date:  2001-07       Impact factor: 2.916

8.  Cow Milk Lactoferrin Possesses Several Catalytic Activities.

Authors:  Svetlana E Soboleva; Sergey E Sedykh; Ludmila I Alinovskaya; Valentina N Buneva; Georgy A Nevinsky
Journal:  Biomolecules       Date:  2019-05-29

9.  Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells.

Authors:  Elisabeth Elass; Maryse Masson; Joël Mazurier; Dominique Legrand
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

10.  Cattle mammary bioreactor generated by a novel procedure of transgenic cloning for large-scale production of functional human lactoferrin.

Authors:  Penghua Yang; Jianwu Wang; Guochun Gong; Xiuzhu Sun; Ran Zhang; Zhuo Du; Ying Liu; Rong Li; Fangrong Ding; Bo Tang; Yunping Dai; Ning Li
Journal:  PLoS One       Date:  2008-10-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.